Medtronic, Inc. (MDT) Reports Q4 EPS of 90c, Misses by 3c
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $88.47 -0.93%
Revenue Growth %: +5.3%
Financial Fact:
Provision for income taxes: 217M
Today's EPS Names:
LGCY, UXIN, SCHL, More
Revenue Growth %: +5.3%
Financial Fact:
Provision for income taxes: 217M
Today's EPS Names:
LGCY, UXIN, SCHL, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $0.90, ex-items, $0.03 worse than the analyst estimate of $0.93. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.29 billion.
Sales from the company's Cardiac and Vascular unit totaled $2.322 billion. Sales from the CRDM segment were $1.32 billion, down about 9 percent year-over-year.
Sales from the company's Cardiac and Vascular unit totaled $2.322 billion. Sales from the CRDM segment were $1.32 billion, down about 9 percent year-over-year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
- BlackBerry shares gain premarket as Q2 results, guidance beat estimates
- Scholastic Corp (SCHL) Misses Q1 EPS by 23c
Create E-mail Alert Related Categories
Earnings, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
